Clinical Trial Update: Vaccine Responsiveness After CAR-T Cell Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing vaccine responsiveness in patients who have received CAR-T cell therapy for B-cell neoplasms; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Neoplasm

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: B-Cell Neoplasm | Phase 1 | Status: COMPLETED